Found 1839 Enz. Inhib. hit(s) with Target = 'Phosphodiesterase' 
Affinity DataIC50: 2.10E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.60E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.70E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 7.80E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 6.10E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 6.80E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+4nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+4nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+4nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 6.30E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 4.90E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 5.10E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 2.80E+4nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.80E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 4.60E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 2.80E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+4nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 7.90E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 3.90E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 3.60E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 2.30E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 2.90E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 7.60E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 4.10E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 3.60E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 3.40E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 930nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 670nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 620nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 2.40E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 900nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 7.30E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 3.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 4.90E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 2.50E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 2.80E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 5.10E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 7.00E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 5.70E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 8.10E+3nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+4nMpH: 6.5 T: 2°CAssay Description:The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...More data for this Ligand-Target Pair
